Cost Comparison of Pressure Sores in the Last 4 Years and Evaluation of the Status of Patients Diagnosed with COVID: Acıbadem Healthcare Group Example

Abstract

It was designed as a retrospective study. Between January 2018 and June 2021, 590 patients who developed pressure ulcers from 16 hospitals affiliated with Acıbadem Healthcare Group (AHG) were identified and classified as Stage 1, Stage 2, Stage 3, Stage 4 and Unstageable pressure ulcer, suspected of deep tissue damage. The cost of treatment was calculated in each category and the total cost per patient for the company was determined. There are two main ways to get data for analysis; 1- Sentinel Event System Reports (for determining the number of patients with pressure ulcers) and 2- Patient Services Pricing Department (for defining the cost of treatment). Costs and costing given by the pricing department with a bottom-up approach are calculated from the patient perspective. Pressure sore cost calculation for COVID-19 patients covers the period from March 2020 to June 2021. Data analysis: Two main ways were used to collect data for analysis; 1- Sentinel Event Notification System Reports (for determining the number of patients with pressure ulcers) and 2- Patient Services Pricing Department (for defining the cost of treatment). Population: All patients who developed pressure ulcers in 16 hospitals affiliated to Acıbadem Healthcare Group since 2018